KPMG at the 44th Annual J.P. Morgan Healthcare Conference

KPMG will be hosting a series of events alongside the 44th annual J.P. Morgan Healthcare Conference. Additionally, as in years past, we will be launching our 2026 Investment Outlook the week of the conference, offering insights into the trends shaping life sciences and healthcare.

Join us to hear from leading industry visionaries, innovative technology creators, emerging growth companies, and members of the investment community. Gain forward-looking perspectives on critical topics that will define the future of healthcare and life sciences.

If you’re planning to be in San Francisco for the J.P. Morgan Healthcare Conference, we want to connect with you!

Add KPMG to your agenda:

KPMG and Kirkland & Ellis panels

Date: Monday, January 12, 2026

Time: 4:00pm – 5:30pm

Location: Kirkland & Ellis Office, 555 California Street, 30th Floor, San Francisco, CA 94104

This annual event will dive into strategies for positioning physician enterprises for long-term success. Topics will include structuring service offerings to meet market needs, optimizing operations for efficiency, and aligning resources to drive sustainable growth. Attendees will gain actionable insights on building scalable, patient-focused organizations that deliver value in an evolving healthcare and life sciences landscape.

Detailed agenda will be available in the coming weeks.

KPMG Cocktail Reception

Date: Tuesday, January 13, 2026

Time: 6:00pm – 8:30pm

Location: Nave Bar (at Hotel Stratford), 242 Powell Street, San Francisco, CA 94102

Join us for an exclusive KPMG networking reception at the J.P. Morgan Healthcare Conference 2026. Enjoy good food, engaging conversations, and valuable networking opportunities.

KPMG + Goodwin Symposium

Date: Wednesday, January 14, 2026

Time: 8:30am – 6:30pm

Location: InterContinental Hotel, 888 Howard Street, San Francisco, CA 94103

Goodwin and KPMG are excited to host our 7th annual Symposium. This event brings together industry leaders to explore the latest trends in AI-driven drug discovery, creative strategies for liquidity in a challenging market, and the evolving healthcare investment landscape. Highlights include panels on innovative financing, M&A in a shifting legal environment, global dealmaking with a focus on China, and a keynote conversation with the CEO of Blueprint Medicines. Don’t miss this opportunity to connect with peers and gain actionable perspectives on the future of life sciences.